Veloxis -hvad nu?
-
Med dagens uhørt vilde stigning - igen igen - i Veloxis Pharmaceuticals er tiden vist inde til at vurdere, om NOVO A/S og Lundbeckfonden gør sig tanker om et evt. salg af majoritetsaktiebeholdningen.
Jeg har ikke lige en oversigt over prisen for udvikling af Envarsus XR over alle årene med forskningsudgifter mm., men jeg vil tro, at ledelsen i de ovennævnte selskaber formentlig lige nu overvejer et salg til en storinvestor for at hente - og forrente - investeringen hjem igen.
De kommende uger bliver et spændende og udfordrende forløb for Veloxis Pharmaceuticals!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind